Efficacy and safety of tixagevimab‐cilgavimab as pre‐exposure prophylaxis for COVID‐19: A systematic review and meta‐analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of tixagevimab‐cilgavimab as pre‐exposure prophylaxis for COVID‐19: A systematic review and meta‐analysis
Authors
Keywords
-
Journal
REVIEWS IN MEDICAL VIROLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-01-09
DOI
10.1002/rmv.2420
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The impact of neutralizing monoclonal antibodies on the outcomes of COVID‐19 outpatients: A systematic review and meta‐analysis of randomized controlled trials
- (2022) Wei‐Ting Lin et al. JOURNAL OF MEDICAL VIROLOGY
- Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
- (2022) Emi Takashita et al. NEW ENGLAND JOURNAL OF MEDICINE
- The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humans
- (2022) Yueh-Ming Loo et al. Science Translational Medicine
- COVID-19 prophylaxis in immunosuppressed patients: Beyond vaccination
- (2022) Ivan Gentile et al. PLOS MEDICINE
- Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
- (2022) Robert Stuver et al. CANCER CELL
- Molnupiravir: A lethal mutagenic drug against rapidly mutating severe acute respiratory syndrome coronavirus 2—A narrative review
- (2022) Sri Masyeni et al. JOURNAL OF MEDICAL VIROLOGY
- Efficacy of anti–SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients
- (2022) Dominique Bertrand et al. KIDNEY INTERNATIONAL
- Protection by a Fourth Dose of BNT162b2 against Omicron in Israel
- (2022) Yinon M. Bar-On et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19
- (2022) Myron J. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Beneficial and harmful effects of monoclonal antibodies for the treatment and prophylaxis of COVID-19: a systematic review and meta-analysis of randomized controlled trials
- (2022) Adrian V. Hernandez et al. AMERICAN JOURNAL OF MEDICINE
- Breakthrough COVID‐19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients
- (2022) Ilies Benotmane et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Tixagevimab/cilgavimab pre‐exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave
- (2022) Ayman Al Jurdi et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Association between AZD7442 (tixagevimab-cilgavimab) administration and SARS-CoV-2 infection, hospitalization and mortality
- (2022) Jennifer Kertes et al. CLINICAL INFECTIOUS DISEASES
- Preventive Medication for COVID-19 Infection
- (2022) Angela G. Malani et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19 morbidity decreases with tixagevimab–cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders/low-vaccine responders
- (2022) Hannah Kaminski et al. KIDNEY INTERNATIONAL
- Characterization of Early-Onset Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients Who Received Tixagevimab-Cilgavimab Prophylaxis
- (2022) Eloy E Ordaya et al. Open Forum Infectious Diseases
- Pre-admission use of sodium glucose transporter-2 inhibitor (SGLT-2i) may significantly improves Covid-19 outcomes in patients with diabetes: A systematic review, meta-analysis, and meta-regression
- (2022) Hikmat Permana et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
- (2022) Kuldeep Dhama et al. Journal of Infection and Public Health
- Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines
- (2021) Wagner Gouvêa dos Santos BIOMEDICINE & PHARMACOTHERAPY
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- PRISMA Reporting Guidelines for Meta-analyses and Systematic Reviews
- (2021) Shipra Arya et al. JAMA Surgery
- Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression
- (2021) Timotius Ivan Hariyanto et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Janus kinase (JAK)-inhibitors and coronavirus disease 2019 (Covid-19) outcomes: a systematic review and meta-analysis
- (2021) Ronal Yosua Limen et al. Expert Review of Anti-Infective Therapy
- Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage
- (2021) Athalia Christie et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Epilepsy and the risk of severe coronavirus disease 2019 outcomes: A systematic review, meta-analysis, and meta-regression
- (2021) Yusak Mangara Tua Siahaan et al. EPILEPSY & BEHAVIOR
- Delirium is a good predictor for poor outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression
- (2021) Timotius Ivan Hariyanto et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Severe Covid-19
- (2020) David A. Berlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
- (2020) Wanbo Tai et al. ANTIVIRAL RESEARCH
- Tocilizumab administration is associated with the reduction in biomarkers of coronavirus disease 2019 infection
- (2020) Timotius Ivan Hariyanto et al. JOURNAL OF MEDICAL VIROLOGY
- Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review and meta-analysis
- (2020) Timotius Ivan Hariyanto et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle–Ottawa Scale and the RTI item bank
- (2014) Andrea V Margulis et al. Clinical Epidemiology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search